Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Francesco Oddone, Vincenzo Scorcia, Michele Iester, Dario Sisto, Stefano De Cilla, Paolo Bettin, Carlo Cagini, Michele Figus, Giorgio Marchini, Luca Rossetti, Gemma Rossi, Tommaso Salgarello, Gian Luca Scuderi & Giovanni Staurenghi. (2022) Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy. Clinical Ophthalmology 16, pages 1707-1719.
Read now
Read now
Francesco Oddone. (2022) Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability. Expert Opinion on Drug Safety 21:10, pages 1259-1268.
Read now
Read now
Gábor Holló, James Kirwan, Fernando Lopez-Lopez, Marina Zimina, Claudia Fassari & Francesco Oddone. (2022) A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy. Current Medical Research and Opinion 38:7, pages 1189-1201.
Read now
Read now
Anastasios-Georgios Konstas, Andreas Katsanos, Georgios P. Athanasopoulos, Irini C. Voudouragkaki, Evangelia S. Panagiotou, Eirini Pagkalidou, Anna-Bettina Haidich, Dimitrios A. Giannoulis, Eleni Spathi, Theodoros Giannopoulos & L. Jay Katz. (2018) Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients. Expert Opinion on Pharmacotherapy 19:18, pages 1981-1988.
Read now
Read now
Articles from other publishers (9)
Barbara Cvenkel & Miriam Kolko. (2022) Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review. Journal of Clinical Medicine 12:1, pages 151.
Crossref
Crossref
E. Ansari, S. Chappiti, J. Pavicic-Astalos, J. C. Pinto-Bonilla, I. Riva, M. Sacchi & F. Saénz-Francés. (2022) Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes. BMC Ophthalmology 22:1.
Crossref
Crossref
Francesco Oddone, James Kirwan, Fernando Lopez-Lopez, Marina Zimina, Claudia Fassari, Gábor Holló, Christoph Faschinger, Enping Chen, Gábor Holló, Gabor Nemeth, Gyorgy Bator, Alexis Tsorbatzoglou, Tamas Acs, Maria Ferencz, Zoltán Sohajda, Jeno Toth, Veronika Volner, Gábor Vogt, Zsolt Biro, Andrea Facskó, János Nemes, Andras Berta, Ilona Elek, Eugene Ng, Francesco Oddone, Gemma Rossi, Luca Rossetti, Michele Vetrugno, Michele Iester, Giorgio Marchini, Vincenzo Scorcia, Giovanni Staurenghi, Carlo Cagini, Tommaso Salgarello, Paolo Bettin, Michele Figus, Gian Luca Scuderi, Stefano De Cilla, Iveta Grundmane, Nora Linavska, Lasma Volksone, Guna Laganovska, Kristine Baumane, Hans Lemij, Kjell Gunnar Gundersen, Marina Zimina, Valery Erichev, Elmira Adbulaeva, Elena Karlova, Ekaterina Zakharova, Irina Panova, Boris Malyugin, Iñaki Rodríguez-Agirretxe, Fernando Lopez-Lopez, Antonio Moreno Valladares, Javier Benitez del Castillo, Rafael Gimenez, Maria Parrilla Vallejo, Jose Javier Garcia-Medina, Alfonso Anton Lopez, Sergio Torregrosa, Jorge Loscos, Miriam Kolko, Ejaz Ansari, David Broadway, Katharine Claridge, Simon Ruben, James Kirwan, Anca Nita, Michael Smith, Areeb Moosavi, Anthony J. W. King & Matthew Kinsella. (2022) Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment. Advances in Therapy 39:8, pages 3501-3521.
Crossref
Crossref
Jose J. Garcia-MedinaJavier Benitez-del-CastilloIñaki Rodríguez-AgirretxeFernando Lopez-LopezAntonio Moreno-ValladaresRafael Gimenez, Maria Parrilla Vallejo, Alfonso Anton lopez, Sergio Torregrosa & jorge loscos. (2022) Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain. Journal of Ocular Pharmacology and Therapeutics 38:3, pages 252-260.
Crossref
Crossref
Sapna Sinha, Wesam Shamseldin Shalaby, Wendy W. Liu, Reza Razeghinejad & L. Jay Katz. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
612
661
.
Francesco Oddone. (2019) A Topical Preservative-free Fixed-dose Combination Remedy in Patients with Glaucoma with Insufficient Response to Monotherapy – The VISIONARY Study. European Ophthalmic Review 13:2, pages 65.
Crossref
Crossref
Janika Nättinen, Antti Jylhä, Ulla Aapola, Minna Parkkari, Alexandra Mikhailova, Roger W. Beuerman & Hannu Uusitalo. (2018) Patient stratification in clinical glaucoma trials using the individual tear proteome. Scientific Reports 8:1.
Crossref
Crossref
Kenji Inoue, Kyoko Ishida & Goji Tomita. (2018) Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil. Japanese Journal of Ophthalmology 62:4, pages 508-516.
Crossref
Crossref
Kenji Inoue, Takeaki Ueda, Kyoko Ishida & Goji Tomita. (2018) Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma. The Open Ophthalmology Journal 12:1, pages 121-126.
Crossref
Crossref